Does a decision aid for prostate cancer affect different aspects of decisional regret, assessed with new regret scales? A randomized, controlled trial

Health Expectations

Volumn 19, Issue 2, 2016, Pages 459-470

  van Tol Geerdink, Julia J ^a   Leer, Jan Willem H ^a   Wijburg, Carl J ^b   van Oort, Inge M ^a   Vergunst, Henk ^c   van Lin, Emile J ^a   Witjes, J Alfred ^a   Stalmeier, Peep F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Decision aid; Patient participation; Prostate cancer; Regret

Indexed keywords

AGED; ANALYSIS OF VARIANCE; CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; DECISION SUPPORT SYSTEM; EMOTION; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATIENT PARTICIPATION; PROSTATIC NEOPLASMS; PSYCHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; VALIDATION STUDY;

AGED; ANALYSIS OF VARIANCE; CHOICE BEHAVIOR; DECISION SUPPORT TECHNIQUES; EMOTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT PARTICIPATION; PROSTATIC NEOPLASMS; QUALITY OF LIFE;

EID: 84961211784     PISSN: 13696513     EISSN: 13697625     Source Type: Journal    
DOI: 10.1111/hex.12369     Document Type: Article

References (35)

1. Shepherd HL, Butow PN, Tattersall MH. Factors which motivate cancer doctors to involve their patients in reaching treatment decisions. Patient Education and Counseling, 2011; 84: 229-235.
2. Legare F, Ratte S, Gravel K, Graham ID. Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals' perceptions. Patient Education and Counseling, 2008; 73: 526-535.
3. Mack JW, Smith TJ. Reasons why physicians do not have discussions about poor prognosis, why it matters, and what can be improved. Journal of Clinical Oncology, 2012; 30: 2715-2717.
4. Smith TJ, Dow LA, Virago E, Khatcheressian J, Lyckholm LJ, Matsuyama R. Giving honest information to patients with advanced cancer maintains hope. Oncology (Williston Park), 2010; 24: 521-525.
5. Peate M, Meiser B, Cheah BC et al. Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer. British Journal of Cancer, 2012; 106: 1053-1061.
6. Wakefield CE, Meiser B, Homewood J, Ward R, O'Donnell S, Kirk J. Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk. Cancer, 2008; 113: 956-965.
7. Berry DL, Wang Q, Halpenny B, Hong F. Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer. Patient Education and Counseling, 2012; 88: 262-267.
8. Brehaut JC, O'Connor AM, Wood TJ et al. Validation of a decision regret scale. Medical Decision Making, 2003; 23: 281-292.
9. Clark JA, Bokhour BG, Inui TS, Silliman RA, Talcott JA. Measuring patients' perceptions of the outcomes of treatment for early prostate cancer. Medical Care, 2003; 41: 923-936.
10. Connolly T, Reb J. Regret in cancer-related decisions. Health Psychology, 2005; 24: S29-S34.
11. Connolly T, Zeelenberg M. Regret in decision making. Current Directions in Psychological Science, 2002; 11: 212-216.
12. Lamont EB, Christakis NA. Prognostic disclosure to patients with cancer near the end of life. Annals of Internal Medicine, 2001; 134: 1096-1105.
13. Kaplowitz SA, Campo S, Chiu WT. Cancer patients' desires for communication of prognosis information. Health Communication, 2002; 14: 221-241.
14. Leydon GM, Boulton M, Moynihan C et al. Cancer patients' information needs and information seeking behaviour: in depth interview study. BMJ, 2000; 320: 909-913.
15. de Haes H. Dilemmas in patient centeredness and shared decision making: a case for vulnerability. Patient Education and Counseling, 2006; 62: 291-298.
16. Livaudais JC, Franco R, Fei K, Bickell NA. Breast cancer treatment decision-making: are we asking too much of patients? Journal of General Internal Medicine, 2013; 28: 630-636.
17. McCammon KA, Kolm P, Main B, Schellhammer PF. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology, 1999; 54: 509-516.
18. Stalmeier PF, Roosmalen MS, Verhoef LC et al. The decision evaluation scales. Patient Education and Counseling, 2005; 57: 286-293.
19. O'Connor AM. Validation of a decisional conflict scale. Medical Decision Making, 1995; 15: 25-30.
20. van Tol-Geerdink JJ, Willem Leer J, Weijerman PC et al. Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid. BJU International, 2013; 111: 564-573.
21. van Tol-Geerdink JJ, Leer JW, van Oort IM et al. Quality of life after prostate cancer treatments in patients comparable at baseline. British Journal of Cancer, 2013; 108: 1784-1789.
22. Elwyn G, O'Connor A, Stacey D et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ, 2006; 333: 417.
23. Deber RB, Kraetschmer N, Irvine J. What role do patients wish to play in treatment decision making? Archives of Internal Medicine, 1996; 156: 1414-1420.
24. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scand, 1983; 67: 361-370.
25. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology, 2000; 56: 899-905.
26. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Medical Care, 2003; 41: 582-592.
27. Larsson US, Svardsudd K, Wedel H, Saljo R. Patient involvement in decision-making in surgical and orthopaedic practice. Effects of outcome of operation and care process on patients' perception of their involvement in the decision-making process. Scandinavian Journal of Caring Sciences, 1992; 6: 87-96.
28. Street RL Jr, Voigt B. Patient participation in deciding breast cancer treatment and subsequent quality of life. Medical Decision Making, 1997; 17: 298-306.
29. Krones T, Keller H, Sonnichsen A et al. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Annals of Family Medicine, 2008; 6: 218-227.
30. Feldman-Stewart D, Tong C, Siemens R et al. The impact of explicit values clarification exercises in a patient decision aid emerges after the decision is actually made: evidence from a randomized controlled trial. Medical Decision Making, 2012; 32: 616-626.
31. Davis JW, Kuban DA, Lynch DF, Schellhammer PF. Quality of life after treatment for localized prostate cancer: differences based on treatment modality. Journal of Urology, 2001; 166: 947-952.
32. Feldman-Stewart D, Kocovski N, McConnell BA, Brundage MD, Mackillop WJ. Perception of quantitative information for treatment decisions. Medical Decision Making, 2000; 20: 228-238.
33. Feldman-Stewart D, Brundage MD, Zotov V. Further insight into the perception of quantitative information: judgments of gist in treatment decisions. Medical Decision Making, 2007; 27: 34-43.
34. Fagerlin A, Pignone M, Abhyankar P et al. Clarifying values: an updated review. BMC Medical Informatics and Decision Making, 2013; 13(Suppl 2): S8.
35. Pieterse AH, de Vries M. On the suitability of fast and frugal heuristics for designing values clarification methods in patient decision aids: a critical analysis. Health Expectations, 2013; 16: e73-e79.